- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Brain 138.2 (2015): S. 398-413.
- Schlagwort
-
-
Hirnkrankheit
Neuropsychiatrie
Nervenkrankheit
- Ereignis
-
Veröffentlichung
- (wo)
-
Erlangen
- (wer)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (wann)
-
2016
- Urheber
-
Skripuletz, Thomas
Manzel, Arndt
Gropengießer, Karoline
Schäfer, Nora
Gudi, Viktoria
Singh, Vikramjeet
Tejedor, Laura Salinas
Jörg, Stefanie
Hammer, Anna
Voss, Elke
Vulinovic, Franca
Degen, Diane
Wolf, Rebecca
Lee, De-Hyung
Pul, Refik
Moharregh-Khiabani, Darius
Baumgärtner, Wolfgang
Gold, Ralf
Linker, Ralf A.
Stangel, Martin
- URN
-
urn:nbn:de:bvb:29-opus4-74766
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Skripuletz, Thomas
- Manzel, Arndt
- Gropengießer, Karoline
- Schäfer, Nora
- Gudi, Viktoria
- Singh, Vikramjeet
- Tejedor, Laura Salinas
- Jörg, Stefanie
- Hammer, Anna
- Voss, Elke
- Vulinovic, Franca
- Degen, Diane
- Wolf, Rebecca
- Lee, De-Hyung
- Pul, Refik
- Moharregh-Khiabani, Darius
- Baumgärtner, Wolfgang
- Gold, Ralf
- Linker, Ralf A.
- Stangel, Martin
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Entstanden
- 2016
Ähnliche Objekte (12)
Dietary fatty acids and susceptibility to multiple sclerosis
Multiple Sklerose - zwischen Grundlagenforschung und klinischer Anwendung
Constitutive activity of NF-kappa B in myeloid cells drives pathogenicity of monocytes and macrophages during autoimmune neuroinflammation
Constitutive activity of NF-kappa B in myeloid cells drives pathogenicity of monocytes and macrophages during autoimmune neuroinflammation
Cardiac Safety Profile of First Dose of Fingolimod for Relapsing-Remitting Multiple Sclerosis in Real-World Settings: Data from a German Prospective Multi-Center Observational Study
Navigating choice in multiple sclerosis management
Dimethyl fumarate in multiple sclerosis: latest developments, evidence and place in therapy
Impact of combined sodium chloride and saturated long-chain fatty acid challenge on the differentiation of T helper cells in neuroinflammation
Impact of combined sodium chloride and saturated long-chain fatty acid challenge on the differentiation of T helper cells in neuroinflammation
The NRF2 pathway as potential biomarker for dimethyl fumarate treatment in multiple sclerosis
Peripheral CD19+ B-cell counts and infusion intervals as a surrogate for long-term B-cell depleting therapy in multiple sclerosis and neuromyelitis optica/neuromyelitis optica spectrum disorders
Krankheitsmodifizierende Therapie der sekundär progredienten Multiplen Sklerose
Dietary fatty acids and susceptibility to multiple sclerosis
Multiple Sklerose - zwischen Grundlagenforschung und klinischer Anwendung
Constitutive activity of NF-kappa B in myeloid cells drives pathogenicity of monocytes and macrophages during autoimmune neuroinflammation
Constitutive activity of NF-kappa B in myeloid cells drives pathogenicity of monocytes and macrophages during autoimmune neuroinflammation
Cardiac Safety Profile of First Dose of Fingolimod for Relapsing-Remitting Multiple Sclerosis in Real-World Settings: Data from a German Prospective Multi-Center Observational Study
Navigating choice in multiple sclerosis management
Dimethyl fumarate in multiple sclerosis: latest developments, evidence and place in therapy
Impact of combined sodium chloride and saturated long-chain fatty acid challenge on the differentiation of T helper cells in neuroinflammation
Impact of combined sodium chloride and saturated long-chain fatty acid challenge on the differentiation of T helper cells in neuroinflammation
The NRF2 pathway as potential biomarker for dimethyl fumarate treatment in multiple sclerosis
Peripheral CD19+ B-cell counts and infusion intervals as a surrogate for long-term B-cell depleting therapy in multiple sclerosis and neuromyelitis optica/neuromyelitis optica spectrum disorders
Krankheitsmodifizierende Therapie der sekundär progredienten Multiplen Sklerose
Dietary fatty acids and susceptibility to multiple sclerosis
Multiple Sklerose - zwischen Grundlagenforschung und klinischer Anwendung
Constitutive activity of NF-kappa B in myeloid cells drives pathogenicity of monocytes and macrophages during autoimmune neuroinflammation
Constitutive activity of NF-kappa B in myeloid cells drives pathogenicity of monocytes and macrophages during autoimmune neuroinflammation
Cardiac Safety Profile of First Dose of Fingolimod for Relapsing-Remitting Multiple Sclerosis in Real-World Settings: Data from a German Prospective Multi-Center Observational Study
Navigating choice in multiple sclerosis management
Dimethyl fumarate in multiple sclerosis: latest developments, evidence and place in therapy
Impact of combined sodium chloride and saturated long-chain fatty acid challenge on the differentiation of T helper cells in neuroinflammation
Impact of combined sodium chloride and saturated long-chain fatty acid challenge on the differentiation of T helper cells in neuroinflammation
The NRF2 pathway as potential biomarker for dimethyl fumarate treatment in multiple sclerosis
Peripheral CD19+ B-cell counts and infusion intervals as a surrogate for long-term B-cell depleting therapy in multiple sclerosis and neuromyelitis optica/neuromyelitis optica spectrum disorders